OBJECTIVE: To determine if fat deposition within mid-thigh muscle, represented by low density lean tissue density, is associated with age, low physical ®tness, hyperleptinemia, hyperinsulinemia and dyslipidemia in women. SUBJECTS: Seventy-two women aged 18 ± 69 y with a wide range of total body fat (10 ± 55%) and maximal aerobic capacity (VO 2 max: 17 ± 61 mlakg À1 amin À1 ). MEASUREMENTS: Mid-thigh muscle, mid-thigh fat, low density lean tissue, intra-abdominal adipose tissue (IAAT) and subcutaneous abdominal fat (by computed tomography, CT), fat mass (FM) and fat-free mass (FFM) (by dual energy xray absorptiometry, DEXA), plasma insulin and leptin (by radioimmunoassay, RIA) and lipoprotein lipid pro®les (by enzymatic methods). RESULTS: VO 2 max declined with age (r À 0.59, P`0.0001) while IAAT and subcutaneous abdominal fat increased with age (r 0.68, r 0.57, r 0.63, P`0.0001). Mid-thigh low density lean tissue correlated with age (r 0.52), VO 2 max (r À 0.56), FFM (r 0.35), fat mass (r 0.68), IAAT (r 0.66) and subcutaneous abdominal fat (r 0.67, all P`0.005). Midthigh low density lean tissue also correlated with fasting plasma leptin, insulin, triacylglycerol (TG), total cholesterol (TC) and low-density-lipoprotein cholesterol (LDL-C) levels (r 0.44, 0.34, 0.41, 0.50, 0.53, respectively, all P`0.005), but not after controlling for body fat and age. Subcutaneous abdominal fat, IAAT, FFM and age were independent predictors of low density lean tissue (P`0.05). CONCLUSIONS: Mid-thigh low density lean tissue is directly related to age and adiposity. Furthermore, it appears that fat accretion in skeletal muscle adversely in¯uences plasma insulin and lipoprotein metabolism in women, but not independently of total adiposity and age.
Introduction
Aging and reduced physical ®tness are associated with an increase in obesity 1 and central body fat, 2 as well as a loss of fat-free mass (FFM). 3 Changes in body composition are important factors in the development of cardiovascular disease (CVD). Mild-to-moderate overweight increases the risk of coronary disease among women 4 and both overall adiposity and abdominal adiposity are associated with mortality risk in older women. 5 Total adiposity, as well as the location of stored fat, are related to glucose and metabolic risk factors for CVD. Speci®cally, the amount of intra-abdominal fat directly correlates with glucose intolerance. 6 Furthermore, the age-associated increase in total and visceral adiposity may contribute to the increase in triglycerides, total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) with age. 7, 8 Thus, aging, inactivity, and total and central adiposity may predispose individuals to CVD, diabetes mellitus and dyslipidemia. 9, 10 To examine the relationships between abdominal obesity and CVD risk factors, many investigators employ computed tomography (CT), a technique which allows the measurement of both intraabdominal and subcutaneous abdominal fat. Moreover, CT is used to quantify muscle area which can be further divided into areas of normal and low attenuation. The areas of low muscle density probably contain more adipose tissue. Earlier studies indicate that lean tissue with a density below the normal range increases with age 11, 12 and obesity 13 in men. In addition, subjects with a higher mid-thigh low density lean tissue, have a lower aerobic ®tness, 14 and reduced muscle attenuation (that is, more fat deposition in the muscle) was associated with insulin resistance in men and premenopausal women. 14, 15 The purpose of the current cross-sectional study was to determine if fat deposition within mid-thigh muscle, represented by low density lean tissue, was associated with age, menopausal status, low physical ®tness, hyperleptinemia, hyperinsulinemia and dyslipidemia, in a relatively large cohort of women. Furthermore, we sought to evaluate these relationships, while controlling for age and body fatness, because we hypothesized that this parameter of regional body composition was positively associated with age and obesity.
Methods

Subjects
Seventy-two women between the ages of 18 ± 69 y with a body mass index (BMI)`40 kgam 2 , were recruited for participation in exercise and weight loss studies, which are ongoing in our laboratory at the University of Maryland (Table 1 ). All women were screened by medical history, physical examination, fasting blood pro®le, 2 h oral glucose tolerance test (OGTT), and a graded exercise treadmill test. Women chosen for this study were healthy, weight stable (no weight change of b 2 kg in the previous two weeks), non-smokers, free of diabetes 16 and CVD, and were not taking any medications known to in¯uence body composition or lipid metabolism. All methods and procedures were approved by the Institutional Review Board of the University of Maryland. All subjects provided written informed consent to participate in the study.
Body composition
Anthropometry. Height (cm) and weight (kg) were measured, to calculate BMI (weight (kg)aheight (m 2 )). Waist circumference, measured at the narrowest point superior to the hip, divided by the hip circumference, measured at its greatest gluteal protuberance, 17 was used to calculate the waist-to-hip ratio (WHR), a measure of body fat distribution. Dual-energy X-ray absorptiometry (DEXA). Fat mass (FM), lean tissue mass and bone mineral content (BMC) were determined by DEXA (Model DPX-L LUNAR Radiation Corp., Madison, WI). FFM is reported as lean tissue plus BMC. All DEXA scans were analyzed using the LUNAR Corporation Version 1.3z DPX-L program for body composition analyses.
Computed tomography (CT). To quantify visceral and abdominal subcutaneous fat, CT scanning of the abdomen was performed using a General Electric (GE) High Speed Advantage 9800 Scanner (Milwaukee, WI). A single 5 mm scan was taken at the L4-L5 region, while the subject was supine with arms stretched above her head. A fat tissue-highlighting technique was used to quantitate the relative proportions of intra-abdominal (IAAT) and subcutaneous adipose tissue areas. Sagittal diameter was determined on the images at the level of the umbilicus and the 4th lumbar intervertebral disk. CT data is expressed as cross-sectional area of tissue (cm 2 ) with the Houns®eld units (HU) for adipose tissue as À190 toÀ30. A second scan performed at the level of the mid-thigh was used to quantify muscle area (HU: 30 to 80), total fat area of the thigh (HU: À190 to À30), and low density lean tissue (HU: 0 ± 29) of the right and left legs. We chose the range of 0 ± 29 HU for measurement of low density lean tissue, rather than 0 ± 34 HU as in previous reports, 13, 15 in order not to overlap the HU which corresponded to muscle. Quanti®cation of regional measures of the mid-thigh are as follows. The left and right leg were separated by a manual tracing. Then, the entire CT image of each leg was selected and in three separate steps each CT area was calculated for each leg. First, the appropriate HU were chosen, which corresponded to adipose tissue. This provided a measurement of total thigh fat because the subcutaneous thigh fat was not actually distinguished from that of visible fat deposited in and around the muscle groups. Second, the HU were changed to those that represent muscle, so that the muscle area of the thigh could be calculated. Lastly, the HU which represented low density lean tissue was selected to enable its measurement from the total leg area.
Maximal oxygen consumption (VO 2 max) VO 2 max was measured during a progressive treadmill test to subjective exhaustion, in which speed was kept constant for each individual, depending on her level of conditioning. The grade was increased from 0 ± 4% at 2 min and was then increased 2% every minute after the third minute, until the subject was unable to continue. Expired air was continuously collected, to determine the fractional concentrations of oxygen and carbon dioxide, as previously described. 18 Validation for attainment of VO 2 max included meeting two of premenopausal vs postmenopausal women *P`0.05, **P`0.001.
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the following three criteria: 1) a plateau in oxygen uptake with an increased work load, as evidenced by a difference in oxygen uptake of`2 ml Á kg À1 Á min À1 ; 2) a respiratory exchange ratio b 1.10 and 3) a maximal heart rate within 10 bpm of the age-predicted maximal value.
Blood analyses
All testing was performed in the morning after a 12 h overnight fast. All subjects were weight stabilized prior to metabolic testing. In those subjects who exercised regularly, blood samples were drawn at least 24 h after the last bout of exercise.
Glucose, insulin, leptin. Arterialized blood samples were collected in heparinized syringes. An aliquot was immediately assayed for plasma glucose concentrations by the glucose oxidase method (Beckman Glucose Analyzer II, Beckman Instruments, Fullerton, CA). The remainder was placed in a prechilled test tube containing 400 units of kallikrein-trypsin inhibitor (Trasylol, Miles Inc., Kankakee, IL) and 1.5 mg EDTAaml of blood in a total volume that was 4% of the sample volume. The blood samples were centrifuged at 4 C and a 1 ml aliquot of plasma was rapidly frozen (80 C) for subsequent hormone analysis. All determinations were performed in duplicate. Immunoreactive insulin was determined by radioimmunoassay (RIA) using human insulin standards and tracer. The antiserum was raised against highly puri®ed human insulin and does not cross react with human proinsulin (`0.1%) (Linco, St Louis, MO). The lower limit of detection of this assay in our laboratory is 12 pmolaL. Intra-and interassay coef®-cients of variation of pooled control sera average 5% and 9%, respectively. Plasma leptin levels were also measured by RIA (Linco). The intra-assay and interassay coef®cient of variation (CV) range from 3.4 ± 8.3% and from 3.0 ± 6.2% respectively.
Lipoprotein lipids. Venous blood samples were transferred into chilled tubes containing 1 mg ethylenediaminetetraacetic acid per cc of blood. Plasma was separated by centrifugation at 4 C for 15 min at 2000 g. TC and triacylglycerol (TG) concentrations were measured by enzymatic methods. 19, 20 Plasma high-density-lipoprotein (HDL) cholesterol was measured in the supernate after precipitation of apolipoprotein B-containing lipoproteins with dextran sulfate. 21 A second precipitation to determine HDL 2 and HDL 3 cholesterol was performed with a high-molecular-weight dextran sulfate. 22 HDL 3 cholesterol was measured in the supernate and HDL 2 cholesterol was calculated as total HDL cholesterol minus HDL 3 cholesterol. Because no subject had a plasma TG concentration b 4.52 mmolaL (400 mgadL), LDL-C was calculated by the Friedewald equation. 23 In our laboratory, the interassay and intra-assay CVs for the measurement of TC were 6.2% and 1.5%, respectively for TG 7.6% and 2.6%, respectively, for HDL cholesterol 9.2% and 2.7%, respectively, and for LDL-C 7.6% and 2.7%, respectively.
Statistical analyses
Relationships between variables were determined by linear regression analyses and calculation of Pearson correlation coef®cients. Stepwise regression was used to determine the independent predictors of mid-thigh low density lean tissue. Data are expressed as mean AE standard error of the mean (s.e.m.) and signi®cance was set at the 0.05 level. All analyses were performed utilizing SPSS software (SPSS Inc., Chicago IL).
Results
Subject characteristics
The subject characteristics for the 72 women, (38 premenopausal and 34 postmenopausal) are shown in Table 1 . Body weight and BMI increased with age (r 0.49, r 0.50, both P`0.001). WHR was 0.80 in all but 11 of the women, so that the majority of this cohort of women had a lower body fat distribution. The wide range of VO 2 max values (17.3 ± 61.0 ml Á kg À1 Á min À1 ) indicates a large variation in physical ®tness in these women. There was a signi®cant decline in VO 2 max across the age span (r À0.59, P`0.0001). Premenopausal women had lower body weight and BMI, and a higher VO 2 max than postmenopausal women (P`0.001).
Total and regional body composition results are presented in Table 2 . Percent body fat and total FM (kg) increased with age (r 0.53, r 0.54, both P`0.0001), whereas there was no relationship between FFM and age. IAAT increased with age (r 0.68, P`0.0001) as did subcutaneous abdominal adipose tissue and sagittal diameter (r 0.57 and r 0.63, both P`0.0001). Postmenopausal women had higher percent body fat and FM than premenopausal women (all P`0.001), whereas FFM did not differ between groups. IAAT, subcutaneous abdominal adipose tissue and sagittal diameter were higher in postmenopausal than premenopausal women (all P`0.001).
Mid-thigh body composition
Relationship with age. There were no signi®cant differences between the right and left mid-thighs for muscle area, total fat area and low density lean tissue area. Therefore, only the right leg values were used in the statistical analyses. Mid-thigh leg total fat and low density lean tissue increased with age (r 0.52 and r 0.58, both P`0.0001; Figure 1, A and B) . In Total and regional body composition AS Ryan and BJ Nicklas contrast, mid-thigh muscle area declined with age (r À0.61, P`0.0001; Figure 1 , C).
Relationship with VO 2 max and body composition. Mid-thigh muscle area positively correlated with VO 2 max, (r 0.71, P`0.0001). In contrast, midthigh low density lean tissue was negatively associated with VO 2 max (r À0.56, P`0.0001). This relationship was independent of age (partial r À0.32, P`0.01). Mid-thigh low density lean tissue correlated with BMI (r 0.69), percent fat (r 0.58), FM (r 0.68), FFM (r 0.35) and midthigh total fat area (r 0.57, all P`0.005) and inversely with mid-thigh muscle area (r À0.44, P`0.0001). Mid-thigh low density lean tissue was also related to central obesity (IAAT r 0.66, Figure  2 , A; subcutaneous abdominal fat r 0.67, Figure 2 , B; sagittal diameter r 0.75; and waist circumference r 0.73, all P`0.005). The relationships between total body fat, IAAT, subcutaneous abdominal fat with mid-thigh low density lean tissue, were each independent of age and menopausal status (partial r 0.49, 0.40, 0.45, all P`0.005).
Multiple regression analyses. The above relationships of age, body composition and VO 2 max to midthigh low density lean tissue, remained highly signi®cant using partial correlation coef®cients controlling for either total body FFM or mid-thigh muscle area. Stepwise regression analysis was used to determine independent predictors of low density lean tissue. In a model with age, menopausal status, VO 2 max, FM, IAAT, subcutaneous abdominal fat and FFM as the variables, subcutaneous abdominal fat (r 2 0.69), FFM (r 2 0.75), age (r 2 0.80), and IAAT (r 2 0.81), (all positive) were independent predictors of low density lean tissue (P`0.0001), explaining 66% of the variance. Table 2 Total body composition by dual energy x-ray absorptiometry (DEXA) and regional body composition by computed tomography (CT) of female subjects Figure 1 Relationship between age and mid-thigh total fat (A: r 0.52, P`0.0001); low density lean tissue area (B: r 0.58, P`0.0001) and muscle area (C: r À0.61, P`0.0001) in women.
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Relationship of CVD risk factors to mid-thigh low density lean tissue Plasma glucose, insulin and leptin. Plasma glucose, insulin and leptin values are presented in Table 3 . Premenopausal women had lower plasma leptin and plasma glucose levels than postmenopausal women (P`0.001). There were no differences between the two groups in plasma insulin levels. Mid-thigh low density lean tissue was signi®cantly associated with higher leptin levels (r 0.44, P`0.001) and insulin levels (r 0.34, P`0.005) and its relationship with fasting concentrations of glucose approached statistical signi®cance (r 0.22, P 0.06). However, after controlling for total adiposity and age, these relationships were no longer signi®cant.
Lipoprotein lipids. Lipoprotein lipid results are presented in Table 3 . Postmenopausal women had higher TC, TG, and LDL cholesterol levels than premenopausal women (all P`0.001). There were no differences between the two groups in HDL cholesterol levels. Mid-thigh low density lean tissue correlated with plasma TG, TC, LDL cholesterol and the LDLaHDL cholesterol ratio (r 0.41, 0.50, 0.53, 0.55, all P`0.001). There was no signi®cant relationship between mid-thigh low density lean tissue and HDL cholesterol, whereas HDL 2 cholesterol was negatively associated with mid-thigh low density lean tissue (r À0.38, P`0.005). After controlling for FM and age, low density lean tissue was not an independent predictor of TC. Similar results were obtained for TG, LDL cholesterol, HDL 2 cholesterol and LDLaHDL cholesterol ratio.
Discussion
This study demonstrates that: 1) mid-thigh low density lean tissue and total leg fat of the mid-thigh are greater in older women, whereas leg muscle area is greater in younger women and 2) mid-thigh low density lean tissue is associated with increased total and central adiposity and reduced physical ®tness, independent of age, in women. There appears to be a relationship between mid-thigh low density lean tissue and hyperinsulinemia, hyperleptinemia and dyslipidemia, but they were not signi®cant when adiposity and age were included in the model. Yet, these ®ndings suggest that muscle with lower than normal attenuation by CT may be another body composition characteristic that occurs with age and increased body fatness, which may lead to the metabolic dysfunction associated with the insulin resistance syndrome. The increase in total body fat observed with age in women of the present study, is accompanied by an Figure 2 Relationship between intra-abdominal adipose tissue area (A: r 0.66, P`0.0001) and subcutaneous adipose tissue area (B: r 0.67, P`0.0001) with mid-thigh low density lean tissue area in women. Total and regional body composition AS Ryan and BJ Nicklas increase in mid-thigh low density lean tissue. We are unaware of other studies which have examined changes in mid-thigh muscle attenuation by CT with age in women. However, reduced muscle attenuation in the psoas major and sacrospinalis muscle groups was previously observed in men and women with age. 12 Likewise, older men had signi®cantly more fat in®ltration in the muscle of the arms and legs than young men, as well as a reduction in muscle area and volume. 11 These changes suggest that with age, alterations in muscle composition occur such that not only does muscle area decline, but it contains more adipose tissue.
A reduction in physical ®tness with age, as well as an increase in obesity, are likely to contribute to the aging-related increase in low density lean tissue observed in the muscle. In our study, women with a higher aerobic capacity, had lower levels of mid-thigh low density lean tissue. Exercise increases the capacity of muscle for lipid utilization. 24 This may partially explain the relationship between VO 2 max and low density lean tissue, such that women with higher aerobic ®tness would, due to exercise, utilize muscle fat more. The relationship of low density lean tissue to VO 2 max was independent of age in our population of women, suggesting that the increased fat deposition in muscle of these older women is related to a decline in ®tness. Mid-thigh low density lean tissue was also related to total and central adiposity, con®rming earlier reports of the direct relationship between low density lean tissue with BMI and mid-thigh adipose volume. 13, 15 Furthermore, the independent association of both subcutaneous abdominal fat and IAAT to midthigh low density lean tissue, suggests that central obesity is an important predictor of fat deposition in the mid-thigh.
Only a few studies have examined the relationship of reduced muscle attenuation to risk factors for disease. Kelley et al 13 found that low density lean tissue increased with obesity and was associated with non insulin-dependent diabetes mellitus (NIDDM) in middle-aged men. Two studies from the same group of researchers showed that glucose uptake, measured under insulin-stimulated conditions, is negatively correlated with thigh muscle of low attenuation. 14, 15 Furthermore, this muscle of low attenuation was as strong a predictor of insulin resistance as visceral fat.
14 Although our only measure of glucose metabolism was fasting insulin, the association between midthigh low density lean tissue and plasma insulin in the present study, indirectly supports their ®ndings. As expected, plasma leptin was highly correlated with total body fat in the women of our study (data not shown). Because of the strong relationships between adiposity and mid-thigh low density lean tissue, it was not surprising that women with higher leptin levels also had greater mid-thigh low density lean tissue. Mid-thigh low density lean tissue was also associated with higher plasma cholesterol, TG, LDL-C and lower HDL 2 -C in our population of women. Although a higher low density lean tissue was related to a worse lipoprotein lipid pro®le, these relationships were not independent of total and central obesity. Thus, the relationships reported between total and LDL-C levels with abdominal obesity by others 8 and observed in our cohort of women (data not shown), are stronger than is the relationship between lipoprotein lipids and fat deposition in the mid-thigh muscle. Since this was a cross-sectional study in healthy women, it remains to be seen whether fat deposition in muscle is a signi®cant risk factor which predisposes individuals to CVD. Likewise, whether mid-thigh low density lean tissue has clinical signi®cance in women with abnormal lipoprotein lipid levels requires further study.
It should be recognized that there are limitations in measuring muscle fat with a single slice CT scan. We have not measured a volume of muscle or fat and cannot extrapolate the ®ndings to the entire leg area. It is also presumed that areas of muscle displaying low attenuation values represent an increased fat content. However, a more direct assessment of the fat content in the muscle requires a muscle biopsy. It is also impossible to discern intra vs extra-cellular fat by CT.
Conclusion
We have studied the body composition, hormones and lipoprotein lipids in a relatively large cohort of women around the ages of 18 ± 70 y. Our results indicate that mid-thigh low density lean tissue is greater in older women than young women, which coincides with the increases in total body and abdominal obesity observed with age. In contrast, leg muscle area declines with age. This suggests that the muscle areas of the thigh contain more adipose tissue in older physically inactive women. Further studies are necessary to examine whether these alterations result in an increase in the clustering of abnormalities of diabetes, dyslipidemia and CVD observed in older women, and whether improvements in physical ®tness and weight loss alter mid-thigh low density lean tissue, to reduce metabolic risk factors for CVD.
